Deferring diagnostic evaluation for suspected deep venous thrombosis using a single dose of anticoagulant: Real-world data from a regionwide care pathway
Inge H Y Luu(Zuyderland Medisch Centrum), Daan J.L. van Twist(Geneeskundige en Gezondheidsdienst), Marc B. I. Lobbes(Maastricht University Medical Centre), Hugo Ten Cate(Maastricht School of Management), Guy J.M. Mostard(Zuyderland Medisch Centrum), Kemal Külcü(Zuyderland Medisch Centrum), Dominique van Mil(University Medical Center Groningen), Marlon H.W. van Berlo(Zuyderland Medisch Centrum), Jacqueline Buijs(Zuyderland Medisch Centrum), J Peeters(Huisarts en Wetenschap), Roel J.W. van Kampen(Zuyderland Medisch Centrum), Jan Palmen(GGD Zuid Limburg), Kon‐Siong G. Jie(Zuyderland Medisch Centrum)
Cited by 3
Related Papers
Thalassemia Syndromes
|Unknown|2009|475
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
|Blood|1989|166
Detection of factor X activation in humans
|Blood|1989|116